CTRI Number |
CTRI/2019/12/022290 [Registered on: 10/12/2019] Trial Registered Prospectively |
Last Modified On: |
07/06/2021 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
AYURVEDIC MANAGEMENT OF GRIDHRASI (SCIATICA) WITH RASONA KSHIRAPAKA |
Scientific Title of Study
|
A CLINICAL EVALUATION OF RASONA KSHIRAPAKA IN THE MANAGEMENT OF GRIDHRASI(SCIATICA) |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
DR VIDHIBEN P PATEL |
Designation |
PG SCHOLAR |
Affiliation |
J S AYURVEDA MAHAVIDYALAYA |
Address |
J S AYURVEDA MAHAVIDYALAYA COLLEGE ROAD NADIAD
Kheda GUJARAT 387001 India |
Phone |
9429624828 |
Fax |
|
Email |
vidhi.patel257@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
DR DHAVAL DHOLAKIYA |
Designation |
READER |
Affiliation |
J S AYURVEDA MAHAVIDYALAYA |
Address |
J S AYURVEDA MAHAVIDYALAYA COLLEGE ROAD NADIAD
Kheda GUJARAT 387001 India |
Phone |
7016786089 |
Fax |
|
Email |
vddhavaldholakiya1910@gmail.com |
|
Details of Contact Person Public Query
|
Name |
DR VIDHIBEN P PATEL |
Designation |
PG SCHOLAR |
Affiliation |
J S AYURVEDA MAHAVIDYALAYA NADIAD |
Address |
J S AYURVEDA MAHAVIDYALAYA COLLEGE ROAD NADIAD
Kheda GUJARAT 387001 India |
Phone |
9429624828 |
Fax |
|
Email |
vidhi.patel257@gmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
J S AYURVEDA MAHAVIDYALAYA |
Address |
J S AYURVEDA MAHAVIDYALAYA COLLEGE ROAD NADIAD 387001 |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DR VIDHIBEN P PATEL |
P D PATEL AYURVEDA HOSPITAL |
kayachikitsa and panchakarma OPD Kheda GUJARAT |
9429624828
vidhi.patel257@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
INSTITUTIONAL ETHICS COMMITTE FOR HUMAN RESEARCH |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: G570||Lesion of sciatic nerve, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
1 rasona kshirapaka
2 placebo tablets |
1. rasona kshirapaka made with classical referance 12.5 gm of rasona(allium sativum),100ml Milk, 100ml water
2. placebo tablets made with wheat flour given along with rasona kshirapaka |
Comparator Agent |
NOT APPLICABLE |
NOT APPLICABLE |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
(1) Presence of Ruk, Toda, Stambha and Spandana in the Sphik, Kati, Uru, Janu, Jangha and Pada.
(2) Sakthiksepadautkshepada Nigraha (S.L.R. test) in affected leg as objective measure for diagnosis as well as for improvement of the treatment.
(3) Patients between the ages of 18 – 60 years. |
|
ExclusionCriteria |
Details |
(1) Pregnant/lactating woman
(2) Patients suffering from pathological condition like bone tumor, spine tuberculosis, scoliosis, kyphosis etc.
(3) Patients having HbA1c >7.5 of diabetes mellitus.
(4) Patients who have taken medication of corticosteroids, psycho pharmacological drugs within last 2 months.
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
EFFECT OF AYURVEDIC MANAGEMENT IN THE PATIENTS OF SCIATICA |
AFTER ALL PATIENTS WILL ENROLLED AND TREATMENT WILL COMPLETED THE DATA WILL BE ASSESSED |
|
Secondary Outcome
|
Outcome |
TimePoints |
NIL |
NOT APPLICABLE |
|
Target Sample Size
|
Total Sample Size="20" Sample Size from India="20"
Final Enrollment numbers achieved (Total)= "23"
Final Enrollment numbers achieved (India)="23" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
10/12/2019 |
Date of Study Completion (India) |
23/07/2020 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
NOT APPLICABLE. THIS THESIS WORK WILL YET TO BE SUBMIT. |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
Study shows
that the females in the age group of 40-60 years are the main sufferers. The
analysis of the Ätura bala revealed
that maximum patients (73.91%) had madhyama
level of viniścita bala.
Observation shows vÄta factor in praká¹›ti as an etiological contributor. ParihÄṇi kÄla (a degenerative
phase) is also a factor in causation of the disease. Majority (60.86%) of the
patients suffered from vÄta-kaphaja type gá¹›dhrasÄ«, and 30.13% from vÄtaja
gá¹›dhrasÄ«, which may be due to modern life style which favors vÄta-kapha
factors. In maximum patient of gṛdhrasī,
vÄyu is aggravated due to mÄrgÄvarodha. In the study, involvement
of kaṇá¸arÄ- Å›irÄ-snÄyu as dūśya was found in all patients i.e.
100% of patients, and involvement of mÄá¹sa
and asthi was found in 91.30% and
86.95% patients respectively.
As an overall effect of the treatment 14 patients had marked response
whereas 5 patients moderately responded. 1 patient had mild response. 3
patients were drop out among them 1 patient was drop out because of irregular
follow up due to family problem and 2 patients drop out reason were unknown. None
of the patients developed any untoward symptoms or any side effects during the
course of the treatment and therefore these medicines in this therapeutic
dosage are safe.
The ultimate
effect was achieved in the patients of gṛdhrasī
by the reduction of pain and controlling the vitiated vÄta-kapha doÅ›a. Along
with that, bá¹›mhaṇa and rasÄyana effects of kṣīrapÄka kalpana should also be accomplished as a part of treatment of vÄtavyÄdhi. Present study reveals that
the selected management has potential effect on gṛdhrasī. Significant improvement was observed in all the symptoms
as well as on SLR. |